Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Aug
13
2015
New York Federal Court Authorizes Pharmaceutical Firm to Engage in Off-label Promotion Using Certain Specific Information and Statements Alert Barnes & Thornburg LLP
Aug
13
2015
This Week’s Health Care Update: Big Changes (Possibly) Ahead for Drug Manufacturers Mintz
Aug
13
2015
Value Of Prophetic Examples re: Lumigan Patent Claims Foley & Lardner LLP
Aug
12
2015
FDA Cites Drug Company for Kim Kardashian Endorsement Mintz
Aug
12
2015
OHIM: DETOX Is Not Descriptive For The Characteristics Of “Beers” Squire Patton Boggs (US) LLP
Aug
11
2015
Medtronic Covidien Settles More than 11,000 Claims Stark & Stark
Aug
11
2015
Lumigan Patents Upheld By Unexpected Results Foley & Lardner LLP
Aug
10
2015
Practical Implications from Amarin Morgan, Lewis & Bockius LLP
Aug
7
2015
Federal Court Grants First Amendment Injunction in Amarin Case Faegre Drinker
Aug
7
2015
Ohio’s New OARRS Standards and Procedures Dinsmore & Shohl LLP
Aug
7
2015
FDA Approves First 3D Printed Pill ArentFox Schiff LLP
Aug
6
2015
Drug Pumps Are Vulnerable to Hacking, FDA Warns Mintz
Aug
6
2015
FY 2016 Medical Device User Fees Announced Covington & Burling LLP
Aug
6
2015
Bill Introduced to Streamline and Clarify Combination Product Regulatory Process Covington & Burling LLP
Aug
6
2015
Pennsylvania Local Breweries May Have Another Venue to Market Their Beer Stark & Stark
Aug
6
2015
Clinical Trial Data: The New EU Regime Morgan, Lewis & Bockius LLP
Aug
5
2015
UPS Deal Continues Trend of Corporate Biofuel Commitments Mintz
Aug
5
2015
Federal Judge Strikes Down Law That Criminalized “Interference with Agricultural Production” Morgan, Lewis & Bockius LLP
Aug
4
2015
The Future of Research Using Electronic Medical Records Data: Precision Medicine Initiative Privacy and Trust Guiding Principles Provide Another Piece of the Puzzle Epstein Becker & Green, P.C.
Aug
4
2015
Professor Eisenberg Analyzes the 101 Exception for Patents Claiming Diagnostic
Aug
4
2015
Individual Inventor Alleges Eli Lilly and BDA Overdosed on Patented Dosage Adherence Tool Womble Bond Dickinson (US) LLP
Aug
4
2015
Delaware District Court Finds Enhanced Patent Indefiniteness Foley & Lardner LLP
Aug
3
2015
In Mexico: Can the Minimum Period of 5 Years Established by NAFTA for Regulatory Data Exclusivity be Extended for Biological Medical Products? Michael Best & Friedrich LLP
Jul
31
2015
Third Circuit Extends Actavis to Reverse Settlement Agreements Involving Non-Cash Consideration McDermott Will & Emery
Jul
31
2015
New CDC Report Discusses Trends In Growing U.S. Heroin Epidemic Jackson Lewis P.C.
Jul
31
2015
Employee’s Positive Return-to-Duty Drug Test Result Warranted Termination Despite Employer’s Use of Low Cutoff Concentrations Jackson Lewis P.C.
Jul
30
2015
Sanofi Seeks Inter Partes Review Of Cabilly Patent Foley & Lardner LLP
Jul
30
2015
Fetal DNA Test Cannot Give Birth to a Patent - Ariosa Diagnostics, Inc., et al. v. Sequenom Inc., et al. McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins